Depression Clinical Trials in New York

Showing 41-60 of 165 trials

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

NCT05531591

The purpose of this study is to assess which antidepressants work the best in older adults who have treatment-resistant depression (TRD), and to test whether treatment-resistant late life depression is associated with declines in memory and attention and brain structure and function.

DepressionDementiaMild Cognitive Impairment+5 more

Centre for Addiction and Mental Health87 participantsStarted Aug 2019

Los Angeles, California, United States • St Louis, Missouri, United States • New York, New York, United States +1 more locations

COMPLETEDNA< 1 mile

Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic

NCT04615416

This study is an open trial designed specifically to address the need for evidence-based treatment delivered via telehealth to individuals that are currently struggling with mental health issues during the COVID-19 pandemic, with the overarching goal of helping residents of New York adversely impacted by the pandemic to effectively manage their anxiety, stress, and depression during this unprecedented time in human history.

Distress, EmotionalEmotional DysfunctionAnxiety+1 more

Teachers College, Columbia University134 participantsStarted May 2020

New York, New York, United States

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic

Depression Trials in Other Cities

Brief Interventions for Coping with Distress

Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression

A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)

An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy

Cognitive Behavior Therapy for Depression

Mechanisms of Emotion Regulation Underlying Successful CBT in Depression

A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression

A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

Anti-suicidal Effects of Buprenorphine In Depressed Individuals

Triage Survey for Psychiatry Research Eligibility

Curio Digital Therapy for the Treatment of Post-partum Depression

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

Treatment for Migraine and Mood (Team-M)

A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder

Financial Incentives to Improve Medication Adherence

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Nitrous Oxide for the Treatment of Major Depressive Disorder

Other Conditions in New York